Article
Distribution of CYP3A4*1/*1B (rs2740574) and CYP3A5*1/*3 (rs776746) Genetic Variants in Renal Transplant Recipients Treated with Sirolimus in Urmia (Iran).
Iranian journal of kidney diseases - 31 May 2026
Makhdoomi Khadijeh, Mivefroshan Azam, Jafari Lale, Ghelich Khan Zahra, Abdi Rad Isa, Bagheri Morteza
Abstract excerpt
Introduction. Rapamycin, also referred to as Sirolimus, is an immunosuppressive medication used in kidney transplantation to prevent organ rejection. Sirolimus is metabolized predominantly by the enzymes CYP3A4 and CYP3A5. The objective of this study was to evaluate the distribution of CYP3A4*1/*1B (rs2740574, -392A > G) and CYP3A5*1/*3 (rs776746, 6986A > G) genetic variants in renal transplant recipients treated...
Topics
Join the communities discussing this publication.
